Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49

Benzinga Newsdesk www.benzinga.com Positive 71.3%

Neg 0% Neu 0% Pos 71.3%

Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $40 to $49.